Press "Enter" to skip to content

New patent expiration for Glaxo Grp drug ADVAIR HFA

2
Copyright © DrugPatentWatch. Originally published at New patent expiration for Glaxo Grp drug ADVAIR HFA

Annual Drug Patent Expirations for ADVAIR+HFA
Annual Drug Patent Expirations for ADVAIR+HFA

Advair Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

ADVAIR HFA drug price trends.

Drug patent litigation for ADVAIR HFA.

This drug has thirty patent family members in fourteen countries.

The generic ingredient in ADVAIR HFA is fluticasone propionate; salmeterol xinafoate. One supplier is listed for this compound. Additional details are available on the fluticasone propionate; salmeterol xinafoate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Glaxo Grp drug ADVAIR HFA
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!